Evidence map›Paper›PMID 28118065›Full record

ArticleCell cycle (Georgetown, Tex.)2017

Myogenic potential of human alveolar mucosa derived cells.

Vadim L Zorin, Andrey A Pulin, Ilya I Eremin, Ivan N Korsakov, Alla I Zorina, Natalia V Khromova, Olga I Sokova, Konstantin V Kotenko, Pavel B Kopnin

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Vadim L Zorina FSBI "Central Clinical Hospital with Outpatient Health Center" , Moscow , Russia.
Andrey A Pulina FSBI "Central Clinical Hospital with Outpatient Health Center" , Moscow , Russia.
Ilya I Eremina FSBI "Central Clinical Hospital with Outpatient Health Center" , Moscow , Russia.
Ivan N Korsakova FSBI "Central Clinical Hospital with Outpatient Health Center" , Moscow , Russia.
Alla I Zorinab Department of Regenerative Medicine at the Human Stem Cells Institute , Moscow , Russia.
Natalia V Khromovac Blokhin Russian Cancer Research Center , Moscow , Russia.
Olga I Sokovac Blokhin Russian Cancer Research Center , Moscow , Russia.
Konstantin V Kotenkod FSBI "Central State Medical Academy" of Business Administration for the President of the Russian Federation , Moscow , Russia.
Pavel B Kopninc Blokhin Russian Cancer Research Center , Moscow , Russia.
Central Clinical Hospital and Polyclinic · RURussian Cancer Research Center NN Blokhin · RUHuman Stem Cells Institute PJSC (Russia) · RUCentral State Medical Academy · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Difficulties related to the obtainment of stem/progenitor cells from skeletal muscle tissue make the search for new sources of myogenic cells highly relevant. Alveolar mucosa might be considered as a perspective candidate due to availability and high proliferative capacity of its cells. Human alveolar mucosa cells (AMC) were obtained from gingival biopsy samples collected from 10 healthy donors and cultured up to 10 passages. AMC matched the generally accepted multipotent mesenchymal stromal cells criteria and possess population doubling time, caryotype and immunophenotype stability during long-term cultivation. The single myogenic induction of primary cell cultures resulted in differentiation of AMC into multinucleated myotubes. The myogenic differentiation was associated with expression of skeletal muscle markers: skeletal myosin, skeletal actin, myogenin and MyoD1. Efficiency of myogenic differentiation in AMC cultures was similar to that in skeletal muscle cells. Furthermore, some of differentiated myotubes exhibited contractions in vitro. Our data confirms the sufficiently high myogenic potential and proliferative capacity of AMC and their ability to maintain in vitro proliferation-competent myogenic precursor cells regardless of the passage number.

Indexed as

Cell DifferentiationMuscle DevelopmentAdipogenesisAdultCell ShapeChondrogenesisFemaleGingivaHumansKaryotypingMaleMesenchymal Stem CellsMesodermMiddle AgedMucous MembraneMyocytes, Smooth Musclealveolar mucosagingivamultipotent differentiationmultipotent mesenchymal stromal cellsmuotubesmyoblastsmyogenic differentiationregenerative medicine

Identifiers

PMID28118065
PMCPMC5384593
OpenAlexW2581727243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.